12 BIOGRAPHICAL SKETCH Sample

Program Director/Principal Investigator (Last, First, Middle):
BIOGRAPHICAL SKETCH Provide the following information for the key personnel and other significant contributors in the order listed on Form Page 2. Follow this format for each person. DO NOT EXCEED FOUR PAGES.
NAME		POSITION TITLE
eRA COMMONS USER NAME
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)
INSTITUTION AND LOCATION	DEGREE (if applicable)		YEAR(s)	FIELD OF STUDY

NOTE: The Biographical Sketch may not exceed four pages. Follow the formats and instructions on the attached sample.

1. Positions and Honors. List in chronological order previous positions, concluding with your present position. List any honors. Include present membership on any Federal Government public advisory committee.

2. Selected peer-reviewed publications (in chronological order). Do not include publications submitted or in preparation.

C. Research Support. List selected ongoing or completed (during the last three years) research projects (federal and non-federal support). Begin with the projects that are most relevant to the research proposed in this application. Briefly indicate the overall goals of the projects and your role (e.g. PI, Co-Investigator, Consultant) in the research project. Do not list award amounts or percent effort in projects.

Program Director/Principal Investigator (Last, First, Middle):		PD/PI Name
BIOGRAPHICAL SKETCH Provide the following information for the key personnel and other significant contributors in the order listed on Form Page 2. Follow this format for each person. DO NOT EXCEED FOUR PAGES.
NAME Carlucci, Joseph Louis		POSITION TITLE Professor of Microbiology
eRA COMMONS USER NAME Carluccij
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)
INSTITUTION AND LOCATION	DEGREE (if applicable)		YEAR(s)	FIELD OF STUDY
Stanford University	Ph.D.		1964	Infectious Diseases
Harvard Medical School	M.D.		1972	Medicine/Parasitology

1. Positions and Honors.

Positions and Employment

1971. Medical Residency, Internal Medicine, Harvard Medical School

1971-1973 EIS Officer, Hospital Infection Section, Bacterial Diseases Branch, CDC, Atlanta, GA

1973-1974 Instructor and Fellow in Medicine, Hematology, Massachusetts General Hospital, Boston, MA

1975. Instructor in Infectious Diseases, Massachusetts General Hospital, Boston, MA

1978. Senior Associate in Infectious Diseases, Children’s Hospital, Boston, MA

1984. Assistant Professor of Pediatrics, Harvard Medical School

1998. Chief, Hemostasis Laboratory, Children’s Hospital, Boston, MA

1993. Professor of Pediatrics, Harvard Medical School, Boston, MA

1998- Professor, Dept. of Infectious Diseases, Harvard School of Public Health

Other Experience and Professional Memberships

1973. Acting Chief, National Mucosal Infections Study

2000. Director of Infectious Diseases Laboratory

1975-present Hospital Epidemiologist (Medical Director Infection Control 2000-present), Children’s Hospital, Boston

1982. President, Society of Hospital Epidemiologists of America

1988 Member, Society for Pediatric Research

1989-present Medical Director Quality Assurance, Children’s Hospital, Boston, MA

1993. Director, American Society for Microbiology, Division F

1997. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control

1998-present Vice-Chair for Health Outcomes, Dept. of Medicine, Children’s Hospital

1998-2001 Steering Committee, NACHRI/CDC Pediatric Prevention Network

Honors

1981. SERC Advanced Research Scholarship, Infectious Disease Society of America

2001 Anthony Steinway Award for Excellence in Teaching (Children’s Hospital)

B. Selected peer-reviewed publications (in chronological order).

(Publications selected from 133 peer-reviewed publications)

1. Luciani JM, Casper J, Goodman BF, Shaw CM, Carlucci JL. Prevention of respiratory virus infections through compliance with frequent hand-washing routines. N Engl J Med 1988 ;318:389-394.

2. Gussmann J, Pratt R, Sideway DG, Sinclair JM, Emmerson MF, Carlucci JL. Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic? JAMA. 1988;158:1548-1552.

3. Gussmann J, Carlucci JL, McGovern JE, Jr., Methodologic issues in nursing home epidemiology. Rev Infect Dis 1989;11:1119-1141.

4. Gussmann J, Emmerson MF, Smyth NE, Platt RI, Sidebottom DG, Carlucci JL. Early hospital release and antibiotic usage with nosocomial staphylococcal bacteremia in two neonatal intensive care unit populations. Amer J Dis Child 1991;149:325-339.

5. Murphy JA, Black RW, Schroeder LC, Weissman ST, Gussman JM, Carlucci JL, Short CJ. Quality of care for children with asthma: the role of social factors and practice setting. Pediatrics 1996;98:379-84.

6. Gussmann J, Carlucci JL, McGovern JE, Jr. Incidence of Staphylococcus epidermidis catheter-related bacteremia by infusions. J Infect Dis 1996;172:320-4.

7. Carlucci JL, Huskins WC. Control of nosocomial antimicrobial-resistant bacteria A strategic priority for hospitals worldwide. Clin Infect Dis 1997;S139-S145.

8. Corning WC, Saylor BM, O’Steen C, Gulapagos L, O’Reilly EJ, Carlucci JL. Hospital infection prevention and control: A model for improving the quality of hospital care in low income countries. Infect Control Hosp Epi. 1999;13:123-35.

9. Handler CJ, Marriott B, Clearwater PT, Carlucci JL. Quality of care at a children’s hospital: the child’s perspective. Arch Pediatr Adolesc Med. 1999;143:1120-7.

10. McKinney D, Poulet KL, Wong Y, Murphy V, Ulright M, Dorling G, Long JC, Carlucci JL, Piper GB. Protective vaccine for Staphylococcus aureus. Science 1999;214:1421-7.

11. Gulazzii L, Kispert ZT, Carlucci JL, Corning WC. Risk-adjusted mortality rates in surgery: a model for outcome measurement in hospitals developing new quality improvement programs. J Hosp Infect 2000;24:33-42.

12. Huebner J, Qui A, Krueger WA, Carlucci JL, Pier GB. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and resistant enterococci. Infect Inmmun 2000; 68:4631-6.

13. Levitan O, Sissy RB, Kenney J, Buchwald E, Maccharone AB, Carlucci JL. Enhancement of neonatal innate defense: Effects of adding an recombinant fragment of bactericidal protein on growth and tumor necrosis factor-inducing activity of gram-positive bacteria tested in vivo. Immun 2000;38:3120-25.

14. Garletti JS, Harrison MC, Collin PA, Miller CD, Otter D, Shaker C, Wren M, Carlucci JL, Makato DG. A randomized trial comparing iodine to a alcohol impregnated dressing for prevention of catheter infections in neonates. Pediatrics. 2001;127:1461-6.

15. Corning WC, Barillo K, Festival MR, Lingonberry S, Lumbar P, Peters A, Pursons M, Carlucci JL, Tella JE. A national survey of practice variation in the use of antibiotic prophylaxis in heart surgery. J Hosp Infect. 2001;33:121-5.

16. Hoboken S, Peterson D, Graveldy L, Carlucci JL. Compliance with hand hygiene practice in pediatric intensive care. Pediatric Crit Care Med. 2001;12:211-214.

17. Hasker S, Pittoui D, Gray L, Zaruccii A, Potter G, Seemore MH, Carlucci JL. Interventional study to evaluate the impact of an antibiotic-infused hand gel in improving hand hygiene compliance. Pediatr Infect Dis J. Accepted for publication.

18. Lander C, Summers R, Murray S, Hummer CJ, Carlucci JL. Pediatrics: Is hospital food more nutritional than mom’s cooking? Pediatrics 2001;11: 140-145.

C. Research Support

Ongoing Research Support

R01 HS35793 Carlucci (PI) 9/01/99-8/30/04

AHRQ

Reducing Antimicrobial Resistance in Low-Income Communities: A Randomized Trial.

This study is a randomized trial of interventions to reduce antimicrobial usage and resistance in low-income communities.

Role: PI

2 R01 AI12345-05 Carlucci (PI) 4/01/01-3/31/06

NIH/NIAID

Bacteriology and Mycology Study of ICU Patients at Risk for Antimicrobial Resistant Bacterial Infections.

The study will perform clinical trials of interventions to reduce antimicrobial resistant infections.

Role: PI

R01- AI24680-04 Peterson (PI) 3/01/01-2/28/06

NIH/NIAID

Virulence and Immunity to Staphylococci.

This study investigates the production of polysaccharide by Staphylococcus aureus and its role in virulence as measured in animal models of infection and its ability to function as a target for protective antibody.

Role: Paid consultant.

2 R01 HL 00000-13 Anderson (PI) 3/01/01-2/28/06

NIH/NHLBI

Chloride and Sodium Transport in Airway Epithelial Cells

The major goals of this project are to define the biochemistry of chloride and sodium transport in airway epithelial cells and clone the gene(s) involved in transport.

Role: Co-Investigator

5 R01 HL 00000-07 Baker (PI) 4/1/01 – 3/31/04

NIH/NHLBI

Ion Transport in Lungs

The major goal of this project is to study chloride and sodium transport in normal and diseased lungs.

Role: Co-Investigator

1 R01 AI12826-01 Hoffman (PI) 9/28/01-9/27/03

NIH/NIAID

Intermountain Child Health Services Research Consortium

This consortium will seek to build pediatric health services research capacity and training in the Intermountain

Region.

Role: Co-Investigator

Completed Research Support

5 RO1 AI10011-05 Herman (PI) 12/01/00 – 11/30/04

NIH/NIAID

Evaluating Quality Improvement Strategies (EQUIS)

The goal of this study was to evaluate quality improvement and collaborative learning to improve asthma care in office-based pediatrics.

Role: Co-Investigator

5 R01 AI098765 Spielman (PI) 7/01/99 -6/30/04

NIH/NIAID

Epidemiology of Emerging Infections #1 T32 AI07654

The goal of this project was to study emerging infections in high risk populations who are treated in emergency room situations.

Role: Co-Investigator

PHS 398/2590 (Rev. 09/07) Page 4 Biographical Sketch Format Page